Close Menu

NEW YORK (360Dx) – Quest Diagnostics announced that all the company's test services for estimating low-density lipoprotein cholesterol, known as LDL-C, now use a new calculation that is more accurate and doesn't require patients to fast from eating food prior to a blood draw.

The development is the result of a license agreement between Quest Diagnostics and Johns Hopkins University.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.